If you are not happy with the results below please do another search
1088 search results for: GW Pharma
Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO Adam George as a director with immediate effect.
Bringing nearly two decades of experience in the pharmaceuticals industry, Adam served … Read the article
Jazz Pharmaceuticals finalized a deal with GW Pharmaceuticals, one of the first and largest producers of legal cannabis-based medicines. GW Pharma ($GWPH) stock jumped nearly 50% after they agreed to sell to Jazz for a landslide of $7.2 billion. The … Read the article
UNITED KINGDOM: Jazz Pharmaceuticals plc and GW Pharmaceuticals announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $20.00 in Jazz … Read the article
Canopy Growth Corp., one of the largest cannabis producers in the world, filed a federal lawsuit in late 2020 against GW Pharmaceuticals, the UK-based cannabis business behind the FDA-approved Epidiolex. At issue is an extraction method that Canopy asserts … Read the article
Two of the biggest players in the marijuana space are heading to federal court over a dispute related to an alleged violation of a patent for a cannabis extraction method.
Canopy Growth Corporation, a Canadian-based marijuana company, filed a lawsuit … Read the article
GW Pharmaceuticals lost $8 million in its latest quarterÂ – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company warned the COVID-19 pandemic could impact sales if fewer patients visit their doctors. Revenue in … Read the article